Subsequently, Dominov et al. (2019) identified a deep intronic point mutation (c.5668-824 C>T) in intron 50 of DYSF in another dysferlinopathy patient. This evidence concerns the gene DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin.